Novozymes A/S (OTCMKTS:NVZMY) Issues Earnings Results

by · The Cerbat Gem

Novozymes A/S (OTCMKTS:NVZMY – Get Free Report) announced its quarterly earnings results on Thursday. The biotechnology company reported $0.48 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.74 by ($0.26), Zacks reports. Novozymes A/S had a net margin of 14.70% and a return on equity of 6.54%.

Novozymes A/S Trading Up 4.2%

Shares of NVZMY stock traded up $2.87 during trading hours on Thursday, hitting $71.52. 57,923 shares of the company’s stock traded hands, compared to its average volume of 24,698. The stock has a market cap of $29.65 billion, a PE ratio of 38.57, a price-to-earnings-growth ratio of 3.08 and a beta of 0.86. The stock’s 50 day simple moving average is $67.55 and its 200 day simple moving average is $62.64. The company has a quick ratio of 1.04, a current ratio of 1.74 and a debt-to-equity ratio of 0.25. Novozymes A/S has a 12 month low of $49.90 and a 12 month high of $75.27.

About Novozymes A/S

(Get Free Report)

Novozymes A/S was a Denmark-based biotechnology company that developed and commercialized enzymes, microorganisms and other biological solutions for industrial and consumer applications. Its products were designed to help customers improve manufacturing processes, reduce resource consumption and develop more sustainable alternatives to conventional chemicals and production methods.

The company served a broad range of industries, including food and beverages, household care, agriculture, animal health, bioenergy and industrial manufacturing.

Featured Stories